Shares of Spire Healthcare Group plc (LON:SPI - Get Free Report) crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 238.45 ($2.95) and traded as high as GBX 250 ($3.09). Spire Healthcare Group shares last traded at GBX 247 ($3.05), with a volume of 140,243 shares trading hands.
Wall Street Analysts Forecast Growth
Several equities analysts have commented on the company. Berenberg Bank increased their price target on Spire Healthcare Group from GBX 286 ($3.53) to GBX 300 ($3.71) and gave the company a "buy" rating in a report on Wednesday, April 17th. JPMorgan Chase & Co. reiterated an "overweight" rating and set a GBX 344 ($4.25) price target on shares of Spire Healthcare Group in a report on Thursday, April 18th.
View Our Latest Research Report on SPI
Spire Healthcare Group Stock Performance
The firm's 50 day moving average price is GBX 238.45 and its 200-day moving average price is GBX 229.81. The firm has a market cap of £996.18 million, a price-to-earnings ratio of 3,521.43, a P/E/G ratio of 1.06 and a beta of 0.99. The company has a debt-to-equity ratio of 170.37, a current ratio of 0.69 and a quick ratio of 0.74.
Spire Healthcare Group Increases Dividend
The business also recently disclosed a dividend, which will be paid on Friday, June 21st. Stockholders of record on Thursday, May 23rd will be paid a GBX 2.10 ($0.03) dividend. This is an increase from Spire Healthcare Group's previous dividend of $0.50. The ex-dividend date of this dividend is Thursday, May 23rd. This represents a dividend yield of 0.89%. Spire Healthcare Group's dividend payout ratio (DPR) is presently 4,285.71%.
Spire Healthcare Group Company Profile
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
See Also
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
